Загрузка...
Acquisition of double mutation in gyrA caused high resistance to sitafloxacin in Helicobacter pylori after unsuccessful eradication with sitafloxacin-containing regimens
BACKGROUND AND AIM: Although sitafloxacin (STFX)-containing regimens are effective rescue treatments for Helicobacter pylori infection, prevalence of fluoroquinolone resistance in H. pylori has increased rapidly worldwide. The change in resistance levels and gyrA mutations, a major cause of fluoroqu...
Сохранить в:
| Опубликовано в: : | United European Gastroenterol J |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5949976/ https://ncbi.nlm.nih.gov/pubmed/29774152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640617737215 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|